Novel treatments for dry eye syndrome

Dry eye syndrome (DES) is a prevalent and multifactorial disease that leads to a self-perpetuating cycle of inflammation and damage to the ocular surface. This results in symptoms such as redness, burning, and blurred vision, which can negatively affect a patient's quality of life. While treatm...

Full description

Saved in:
Bibliographic Details
Published in:Current opinion in pharmacology 2024-04, Vol.75, p.102431-102431, Article 102431
Main Authors: Roucaute, Esther, Huertas-Bello, Marcela, Sabater, Alfonso L.
Format: Article
Language:English
Subjects:
Dry Eye Syndromes - diagnosis
Dry Eye Syndromes - drug therapy
Dry Eye Syndromes - etiology
Eye
Humans
Inflammation - complications
Quality of Life
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dry eye syndrome (DES) is a prevalent and multifactorial disease that leads to a self-perpetuating cycle of inflammation and damage to the ocular surface. This results in symptoms such as redness, burning, and blurred vision, which can negatively affect a patient's quality of life. While treatments are available to manage DES, they only temporarily relieve symptoms. Furthermore, long-term use of certain medications can cause harm to the ocular surface. Therefore, there is a need for safer and effective treatments for DES. This review highlights the latest advancements in DES therapy, providing valuable insights into ongoing efforts to improve patient outcomes. •Dry eye syndrome is a prevalent condition that can significantly impact patients' quality of life.•Traditional treatments for dry eye syndrome, such as lubricating eye drops, may not be effective for all patients.•A better understanding of the pathophysiology of dry eye disease has led to novel therapies targeting new pathways.
ISSN:1471-4892
1471-4973
DOI:10.1016/j.coph.2024.102431